Real-World Study Shows Durable Cardiovascular Protection with Repatha Target RWE, a leading organization in modern real-world evidence (RWE) generation and a trusted partner for regulatory-grade research, has announced significant new…
EdgeOne Medical Appoints Industry Veteran Marty Shelton as Chief Operating Officer to Advance Operational Excellence, Client Value, and Long-Term Growth EdgeOne Medical, a trusted provider of development and testing services…
Allurion Unveils Initial Results on Program + Tirzepatide Combo Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR)—a global leader in innovative, non-surgical weight-loss technology—today announced encouraging initial results from…
PrimeStore® MTM Shows Strong Validation for Global TB Testing Longhorn Vaccines & Diagnostics (“Longhorn”), a One Health-focused biotechnology company advancing innovative diagnostics and antibody platforms to address global public health…
ReAlta Life Sciences Strengthens Leadership Team with Appointment of Dr. Howard Berman as Executive Chairman ReAlta Life Sciences Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company pioneering next-generation medicines…
Zetagen Therapeutics Announces Oversubscribed $12.9M Series B1 Financing to Advance Breakthrough Intratumoral Therapies for Breast Cancer Zetagen Therapeutics, Inc., a privately held clinical-stage biopharmaceutical company advancing first-in-class intratumoral therapies for…
Enigma Biomedical USA Awarded $2 Million Grant from The Michael J. Fox Foundation to Advance Novel α-Synuclein PET Imaging Biomarker for Parkinson’s Disease Enigma Biomedical USA (EB USA) today announced…
Vyome Holdings Announces Appointment of Renowned Oncologist Dr. Aditya Bardia as Senior Medical Advisor to Advance VT-1953 for Malignant Fungating Wounds Vyome Holdings, Inc. (“Vyome”) (NASDAQ: HIND), a clinical-stage healthcare…
Pathway to Cures Invests in SeraGene Therapeutics The fifth paragraph of the original release dated November 19, 2025, should read: Pathway to Cures joins Hextwo Capital as early investors in…
CareDx Announces Publication of New SHORE Study Demonstrating the Prognostic Power of HeartCare® for Heart Transplant Recipients in the Journal of Heart and Lung Transplantation CareDx, Inc. (Nasdaq: CDNA), a…
Kelonia Therapeutics Announces Late-Breaking Oral Presentation Showcasing First-in-Human Data for KLN-1010, an In Vivo BCMA CAR-T Gene Therapy, at ASH 2025 Kelonia Therapeutics, Inc., a clinical-stage biotechnology company advancing a…
Microsize and Schedio Group Sign Agreement to Acquire Lonza’s Micro-Macinazione Facility in Switzerland, Advancing a Transatlantic Particle Engineering Platform Microsize, a prominent contract development and manufacturing organization (CDMO) known for…